Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Objective: To assess the association between calcidiol status (25D3) and metabolic syndrome in 40-to-60-year-old Mexican women.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Methods: A retrospective cross-sectional study was conducted in 202 women from the northeast of Mexico.

Source: Abstract.

According to the stages of reproductive aging workshop criteria, STRAW + 10, women were reproductive, with regular menstrual cycles or no present changes, and postmenopausal, with absence of menstrual cycle for ≥12 months [].

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Calcidiol Status and Metabolic Syndrome in 40 to 60-Year-Old Women: Association with Metabolic Components

Cross-sectional study · Nutrients · 2026

Original publication title

Calcidiol Status and Metabolic Syndrome in 40 to 60-Year-Old Women: Association with Metabolic Components

Alexandra Tijerina-Sáenz; Ana Paula Romo-Uribe; Adbel Zaid Martínez-Báez; Elizabeth Solís-Pérez; Michel Stéphane Heya; Cristina Bouzas; Daniela Rodrigues; Josep A. Tur

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Background: Metabolic syndrome (MetS) is a public health problem with high prevalence in adult Mexican women. Evidence suggest that vitamin D deficiency is prevalent among individuals’ metabolic disorders, obesity, and insulin resistance. Objective: To assess the association between calcidiol status (25D3) and metabolic syndrome in 40-to-60-year-old Mexican women. Methods: A retrospective cross-sectional study was conducted in 202 women from the northeast of Mexico. The diagnosis of MetS was established using the definition of the International Diabetes Federation. Calcidiol was quantified using a validated method of liquid chromatography (HPLC-UV).

Results: The prevalence of MetS was 59.9% and calcidiol deficiency (<20 ng/dL) 67.8%. Women with MetS had lower calcidiol levels than those in the NoMetS group (9.0 ng/mL vs. 17.2 ng/mL; p = 0.003). Presence of MetS was associated with deficient calcidiol levels (p = 0.023). Most MetS components showed an increased likelihood, 1.7 to 9.1%, of the presence of MetS at deficient (<20 ng/dL) and low (<30 ng/mL) calcidiol levels. Conclusions: Maintaining calcidiol levels at or above 30 ng/mL has been stated as protective for 40 to 60-year-old women; however, vitamin D supplementation as a protective strategy against MetS cannot be recommended.

Longitudinal and intervention studies are needed to clarify causality and evaluate the benefits of vitamin D in women with metabolic syndrome.

Authors’ abstract

Background: Metabolic syndrome (MetS) is a public health problem with high prevalence in adult Mexican women. Evidence suggest that vitamin D deficiency is prevalent among individuals’ metabolic disorders, obesity, and insulin resistance. Objective: To assess the association between calcidiol status (25D3) and metabolic syndrome in 40-to-60-year-old Mexican women. Methods: A retrospective cross-sectional study was conducted in 202 women from the northeast of Mexico. The diagnosis of MetS was established using the definition of the International Diabetes Federation. Calcidiol was quantified using a validated method of liquid chromatography (HPLC-UV).

Results: The prevalence of MetS was 59.9% and calcidiol deficiency (<20 ng/dL) 67.8%. Women with MetS had lower calcidiol levels than those in the NoMetS group (9.0 ng/mL vs. 17.2 ng/mL; p = 0.003). Presence of MetS was associated with deficient calcidiol levels (p = 0.023). Most MetS components showed an increased likelihood, 1.7 to 9.1%, of the presence of MetS at deficient (<20 ng/dL) and low (<30 ng/mL) calcidiol levels. Conclusions: Maintaining calcidiol levels at or above 30 ng/mL has been stated as protective for 40 to 60-year-old women; however, vitamin D supplementation as a protective strategy against MetS cannot be recommended.

Longitudinal and intervention studies are needed to clarify causality and evaluate the benefits of vitamin D in women with metabolic syndrome.

Publication and source details

Original title: Calcidiol Status and Metabolic Syndrome in 40 to 60-Year-Old Women: Association with Metabolic Components

Alexandra Tijerina-Sáenz; Ana Paula Romo-Uribe; Adbel Zaid Martínez-Báez; Elizabeth Solís-Pérez; Michel Stéphane Heya; Cristina Bouzas; Daniela Rodrigues; Josep A. Tur

Nutrients · 2026

* Correspondence: pep.tur@uib.es© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Programa de Apoyo a la Investigación Científica y Tecnológica PAICYT SA1957-21 Universidad Autónoma de Nuevo León. C.B.https://ror.org/01fh86n78 Instituto de Salud Carlos IIIhttps://ror.org/00ca2c886 CIBEROBN CB12/03/30038 European Regional Development Fundhttps://ror.org/01rkhv978 IDISBA Grants (FOLIUM, PRIMUS, SYNERGIA and LIBERI) This study was partially funded by the Programa de Apoyo a la Investigación Científica y Tecnológica (PAICYT SA1957-21), Universidad Autónoma de Nuevo León. C.B., and J.A.T. were funded by the Instituto de Salud Carlos III through the Fondo de Investigación para la Salud (CIBEROBN CB12/03/30038), which is cofounded by the European Regional Development Fund; and IDISBA Grants (FOLIUM, PRIMUS, SYNERGIA and LIBERI). The funding sponsors had no role in the design of this study; in the collection, analysis or interpretation of the data; in the writing of this manuscript; or in the decision to publish the results.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:07:17.315564+00:00

DOI: 10.3390/nu18142311 · PMC13415389